This study delves into the safety and effectiveness of combining hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) with cytoreductive surgery (CRS) in patients with peritoneal carcinomatosis (PC) who need diaphragm resection. Researchers compared HITAC to traditional intraperitoneal chemotherapy (HIPEC). Results show that HITAC is a viable option with similar safety profiles, and it might offer benefits for […]
Author: STITCHES Newsletter
The Great Gastric Cancer Debate: Is Neoadjuvant Radiation Worth Adding to Chemo?
This study navigates the ongoing debate over whether neoadjuvant radiation should be combined with chemotherapy in the treatment of resectable gastric cancer. While awaiting results from specific clinical trials, experts discuss the pros and cons. Neoadjuvant radiation may be better tolerated and improve pathologic response, especially for certain tumor locations. However, it hasn’t shown a […]
Diverse Asian American Groups Show Varying Pancreatic Cancer Survival Rates
This study delves into pancreatic cancer outcomes in the disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population, which is often underrepresented in scientific research. Analyzing data from 296,448 patients, it reveals that AANHPI patients, as a whole, exhibited better median survival than Caucasians and African Americans. Notably, survival rates varied among AANHPI subpopulations, […]
Mesenteric Lymph Nodes Not Linked to Ovarian Cancer Survival
Researchers examined the role of mesenteric lymph nodes (MLNs) in digestive resection for advanced ovarian cancer (OC) with peritoneal metastases. Out of 159 patients, 77 underwent digestive resection, with 61.1% having MLNs examined, and 56.8% showed involvement. Surprisingly, MLN status didn’t significantly impact overall survival or progression-free survival. This calls for further systematic and standardized […]
Repeat Cytoreduction and HIPEC Boost Survival in Recurrent Appendiceal Adenocarcinoma
When dealing with recurring mucinous appendiceal adenocarcinoma, undergoing repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be a game-changer. This study from MD Anderson Cancer Center reveals that patients who opt for repeat CRS/HIPEC enjoy similar recurrence-free survival compared to those initially treated, and even better overall survival than patients relying solely on […]
Sarcopenia Development During Neoadjuvant Therapy Spells Trouble for Esophageal Adenocarcinoma Patients
This study explored how sarcopenia, muscle loss often seen in cancer patients, impacts outcomes for esophageal adenocarcinoma patients undergoing neoadjuvant therapy. Among 71 patients, those who developed sarcopenia before surgery had significantly worse overall survival compared to those who were sarcopenic at diagnosis or experienced no change in muscle status. The cause of death in […]
Women Fare Better in Surgical Outcomes for Inflammatory Bowel Disease
In this study, researchers delved into surgical outcomes for inflammatory bowel disease patients based on their sex. Analyzing data from over 3,000 patients, they discovered that women had lower odds of serious adverse events compared to men. This difference was particularly notable in patients with ulcerative colitis, where women had a 54% lower risk of […]
Innovative Imaging Technique Shows Promise for Assessing Organ Perfusion During Laparoscopic Surgery
This groundbreaking study introduces Imaging Photoplethysmography (IPPg) as a new method for quantitatively evaluating organ perfusion during laparoscopic surgeries. In clinical settings, researchers successfully used a laparoscope connected to a digital monochrome camera, along with green light illumination, to assess organ perfusion in cancer patients. They found that IPPg could visualize and quantify perfusion gradients […]
Robotic Hepatectomy Shows Promise in Treating Malignant Liver Diseases
This groundbreaking study analyzed the outcomes of robotic hepatectomy for five major malignant liver diseases. Among the 210 patients who underwent this procedure, including cases like colorectal liver metastases and hepatocellular carcinoma, the results were promising. A favorable 5-year overall survival benefit was observed across these disease processes. The robotic platform demonstrated its prowess in […]
EUS-Guided Radiofrequency Ablation: A Safe and Effective Alternative for Left Adrenal Tumors
Researchers conducted a study at Asan Medical Center to assess the feasibility, effectiveness, and safety of EUS-guided radiofrequency ablation (EUS-RFA) for treating left adrenal tumors. The results were promising, with a 100% technical success rate in performing EUS-RFA. Most patients (73%) achieved a complete response after a median of 2 EUS-RFA sessions. Importantly, no moderate […]
